RXPA 380 is a C-terminal specific angiotensin-converting enzyme (ACE) inhibitor with a Ki of 3 nM. RXPA 380 inhibits C-domain mutants of human recombinant ACE with an IC50 of 2.5 nM[1].
Molecular Weight:
617.63
CAS Number:
[564479-79-4]
Formula:
C33H36N3O7P
Target:
Angiotensin-converting Enzyme (ACE)
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted